ESC 365 - The association between LDL-C reduction and new events of diabetes and AMI during PCSK9 inhibitor treatment: A meta-analysis

ESC Premium Access

The association between LDL-C reduction and new events of diabetes and AMI during PCSK9 inhibitor treatment: A meta-analysis

Session: Poster session 1 - Lipids

Topic: Lipids (Epidemiology and Prevention)

Speaker: Doctor C. Lewinter (Stockholm, SE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Christian Lewinter

Karolinska University Hospital, Stockholm (Sweden)

0 follower

14 more presentations in this session

Associations between very low concentrations of LDL-cholesterol and health outcomes in the reasons for geographical and racial differences in stroke (REGARDS) Study

Speaker: Professor P. Penson (Liverpool, GB)

Cholesterol efflux capacity and incident atherosclerotic cardiovascular disease events in a Japanese general population

Speaker: Doctor M. Ogura (Urayasu, JP)

Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South-Africa, Middle East and China: results of the dyslipidemia international study (dysis)

Speaker: Doctor A. Gitt (Ludwigshafen, DE)

Comparison of plaque microstructures between two high-intensity statin therapies: rosuvastatin versus atorvastatin

Speaker: Doctor S. Honda (Osaka, JP)

Sex-related differences in clinical characteristics, low-density lipoprotein cholesterol control and cardiovascular outcomes in familial hypercholesterolemia.

Speaker: Doctor T. Doi (Herlev, DK)

Access the full session

Poster session 1 - Lipids

Speakers: Doctor C. Lewinter, Professor P. Penson, Doctor M. Ogura, Doctor A. Gitt, Doctor S. Honda...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources